Vishay (VSH) Q1 2026 Earnings Call Transcript

Vishay Intertechnology delivered a solid Q1 beat, with revenue of $839 million, up 4.8% sequentially and 17.3% year over year, above guidance of $800 million to $830 million. Gross margin improved to 21% and book-to-bill rose to 1.34, while backlog climbed 21% to $1.6 billion, signaling stronger demand visibility. Management raised Q2 revenue guidance to $875 million to $905 million, cited continued pricing improvement and AI growth above $100 million this year, but free cash flow remained negative due to $111 million of CapEx and the company kept share buybacks on hold.

Analysis

VSH is transitioning from a cost-recovery story to a capacity-monetization story: the key second-order effect is not just better demand, but higher conversion of backlog into revenue as lead times normalize. That matters because the company is still spending heavily, so the equity re-rates only if investors believe incremental volume will outgrow the remaining CapEx drag before the cycle rolls over. The strongest signal here is that pricing is turning from a defensive input offset into a multi-quarter ASP tailwind, which should expand margins faster than consensus models that anchor on flat mix.

The competitive setup is improving in VSH's favor. Automotive and industrial customers appear to be requalifying suppliers and dual-sourcing more aggressively, which benefits vendors with visible capacity and hurts smaller peers that cannot offer supply assurance or global qualification coverage. The hidden beneficiary may be distributors: lower channel inventory plus rising POS gives them leverage to push replenishment orders earlier, which can temporarily inflate book-to-bill and backlog quality even if end demand is only mid-single-digit.

The main risk is timing, not demand. If Germany ramp slips by even one to two quarters or Newport qualification progresses slower than expected, VSH will still carry the depreciation, labor, and CapEx burden without the margin lift, which makes the stock vulnerable over the next 2-3 quarters despite the upbeat order data. A second risk is that AI exposure becomes a crowded trade: if component shortages ease faster than expected, the pricing benefit could fade before the new capacity is fully absorbed.

Contrarian read: the market may be underestimating how much of the upside is already embedded in the backlog and how little financial flexibility remains until free cash flow turns positive. That argues for owning VSH only if you have conviction that the margin inflection is arriving in 2H26, not merely that revenue is improving. If not, this remains a good operating story but a potentially mediocre stock until CapEx peaks and buybacks can resume.

Key Decisions for Investors

• Long VSH into the next 1-2 quarters only if you can tolerate cash burn: prefer a starter long at current levels with a 6-9 month horizon, targeting a re-rating if gross margin tracks above guidance and backlog converts cleanly; trim on any sign of qualification slippage.
• Pair trade: long VSH / short a weaker analog or passive peer with less capacity visibility over the next 3-6 months; thesis is that supply assurance and pricing should separate winners from laggards during the current industrial/auto restock phase.
• Sell downside protection on VSH only after the next Q2 print if management confirms Germany install progress and ASP uplift; the cleanest structure is a cash-secured put or put spread to monetize elevated implied vol while limiting exposure to execution risk.
• Avoid chasing after a gap-up: use pullbacks tied to CapEx or tax-rate noise to build exposure, since the market can fade 'good order' headlines until it sees FCF troughing and margin expansion.
• For a more tactical trade, consider a 3-6 month call spread in VSH rather than outright stock if you want exposure to the margin inflection with limited risk to delayed ramp timing.